文献速递冠心病血脂与心血管预防

高敏心肌肌钙蛋白对肾功能不全疑似急性冠脉综合征患者的风险分层

High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.
PubMed 文献 · Circulation · 2017-10-04

这项前瞻性多中心研究纳入4726例疑似急性冠脉综合征患者,其中904例(19%)存在肾功能不全。高敏肌钙蛋白I低于5 ng/L对肾功能不全患者主要终点阴性预测值为98.4%、灵敏度98.9%,但仅识别17%为低危;99百分位阈值诊断特异度70.9%、阳性预测值50.0%,均低于肾功能正常者。肾功能不全且肌钙蛋白升高者1年后续心梗或心源性死亡风险更高(24% vs 10%,校正HR 2.19)。

要点

  • 肾功能不全患者肌钙蛋白<5 ng/L阴性预测值98.4%,但仅17%被归为低危。
  • 99百分位阈值在肾功能不全者中特异度70.9%、阳性预测值50.0%,低于肾功能正常者。
  • 肾功能不全且肌钙蛋白升高者1年心梗或心源性死亡风险24%,校正HR 2.19。

核心结论

  • 在疑似急性冠脉综合征患者中,高敏肌钙蛋白对肾功能不全者识别出更少的低危和更多的高危患者,但诊断1型心梗的特异度较低。
  • 无论诊断如何,肾功能不全且肌钙蛋白升高的患者发生主要心脏事件的风险是肾功能正常者的2倍,应考虑进一步检查和治疗。

研究设计与样本

  • 前瞻性多中心研究,连续纳入疑似急性冠脉综合征患者4726例,其中904例(19%)存在肾功能不全(估算肾小球滤过率<60mL/min/1.73m2)。

主要发现

  • 肌钙蛋白<5 ng/L对肾功能不全者主要终点阴性预测值98.4%(95%CI 96.0%-99.7%)、灵敏度98.9%(95%CI 97.5%-99.9%),仅17%为低危;肾功能正常者56%为低危(P<0.001),阴性预测值99.7%(95%CI 99.4%-99.9%)、灵敏度98.4%(95%CI 97.2%-99.4%)。
  • 99百分位阈值(女性16 ng/L、男性34 ng/L)对肾功能不全者阳性预测值50.0%(95%CI 45.2%-54.8%)、特异度70.9%(95%CI 67.5%-74.2%);肾功能正常者分别为62.4%(95%CI 58.8%-65.9%)和92.1%(95%CI 91.2%-93.0%)。
  • 1年时,肌钙蛋白>99百分位且肾功能不全者后续心梗或心源性死亡发生率为24%,肾功能正常者为10%,校正HR 2.19(95%CI 1.54-3.11)。

关键数值与推荐

  • 风险分层阈值:高敏肌钙蛋白I<5 ng/L。
  • 99百分位诊断阈值:女性16 ng/L,男性34 ng/L。
  • 肾功能不全定义:估算肾小球滤过率<60mL/min/1.73m2。

临床怎么用

  • 对肾功能不全的疑似急性冠脉综合征患者,肌钙蛋白<5 ng/L仍可辅助识别低危,但需注意仅少部分患者符合。
  • 肌钙蛋白升高时需结合临床综合判断,因特异度较低,避免仅凭99百分位阈值诊断1型心梗。
  • 肾功能不全且肌钙蛋白升高者1年心脏事件风险高,应考虑进一步检查和治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-sensitivity cardiac troponin testing may improve the risk stratification and diagnosis of myocardial infarction, but concentrations can be challenging to interpret in patients with renal impairment, and the effectiveness of testing in this group is uncertain. METHODS: In a prospective multicenter study of consecutive patients with suspected acute coronary syndrome, we evaluated the performance of high-sensitivity cardiac troponin I in those with and without renal impairment (estimated glomerular filtration rate <60mL/min/1.73m2). The negative predictive value and sensitivity of troponin concentrations below the risk stratification threshold (5 ng/L) at presentation were reported for a primary outcome of index type 1 myocardial infarction, or type 1 myocardial infarction or cardiac death at 30 days. The positive predictive value and specificity at the 99th centile diagnostic threshold (16 ng/L in women, 34 ng/L in men) was determined for index type 1 myocardial infarction. Subsequent type 1 myocardial infarction and cardiac death were reported at 1 year. RESULTS: Of 4726 patients identified, 904 (19%) had renal impairment. Troponin concentrations <5 ng/L at presentation identified 17% of patients with renal impairment as low risk for the primary outcome (negative predictive value, 98.4%; 95% confidence interval [CI], 96.0%-99.7%; sensitivity 98.9%; 95%CI, 97.5%-99.9%), in comparison with 56% without renal impairment (P<0.001) with similar performance (negative predictive value, 99.7%; 95% CI, 99.4%-99.9%; sensitivity 98.4%; 95% CI, 97.2%-99.4%). The positive predictive value and specificity at the 99th centile were lower in patients with renal impairment at 50.0% (95% CI, 45.2%-54.8%) and 70.9% (95% CI, 67.5%-74.2%), respectively, in comparison with 62.4% (95% CI, 58.8%-65.9%) and 92.1% (95% CI, 91.2%-93.0%) in those without. At 1 year, patients with troponin concentrations >99th centile and renal impairment were at greater risk of subsequent myocardial infarction or cardiac death than those with normal renal function (24% versus 10%; adjusted hazard ratio, 2.19; 95% CI, 1.54-3.11). CONCLUSIONS: In suspected acute coronary syndrome, high-sensitivity cardiac troponin identified fewer patients with renal impairment as low risk and more as high risk, but with lower specificity for type 1 myocardial infarction. Irrespective of diagnosis, patients with renal impairment and elevated cardiac troponin concentrations had a 2-fold greater risk of a major cardiac event than those with normal renal function, and should be considered for further investigation and treatment. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01852123.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Miller-Hodges E, Anand A, Shah ASV, et al. High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome. Circulation. 2017. PMID: 28978551. doi:10.1161/CIRCULATIONAHA.117.030320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。